hsa-miR-661 is known to be expressed at early time points of SNAI1-induced EMT and promote invasion of breast cancer cells by degrading two target genes, NECTIN1 (cell-cell adhesion protein), and STARD10 (lipid transferase) [84]. Here, NECTIN1 is linked to breast cancer.